The largest database of trusted experimental protocols

Aeb071

Manufactured by Selleck Chemicals
Sourced in United States

AEB071 is a chemical compound used as a laboratory reagent. It serves as a tool for researchers and scientists in various fields of study. The core function of AEB071 is to facilitate specific chemical reactions and analyses within a controlled laboratory environment. No further details or interpretations about its intended use are provided.

Automatically generated - may contain errors

4 protocols using aeb071

1

Breast Cancer Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast cancer MCF7 cells were cultured as described37 (link). T47D and Hs578T cells were obtained from the Bioresource Collection and Research Center (Hsinchu, Taiwan) and cultured in RPMI 1640 medium or DME medium (Sigma-Aldrich) supplemented with 10 μg/ml insulin (Thermo Fisher Scientific). All cells were maintained in medium supplemented with 10% fetal bovine serum (Thermo Fisher Scientific). Plasmid or siRNA transfection for all cells was performed using Lipofectamine 2000 as described37 (link). To induce EGFR signaling, EGF (Peprotech) was added to serum-free T47D culture medium with subsequent incubation for 24 h. Afatinib, AZD9291, PD153035, and AEB071 were purchased from Selleckchem, and the MEK inhibitor U0126 was obtained as described38 (link).
+ Open protocol
+ Expand
2

Small-molecule inhibition of cellular pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
AEB071 was purchased from Selleckchem (S2791) and prepared as a 10 mM stock solution in DMSO. IDE196 was purchased from Chemgoods (C-1368) and prepared as a 10 mM stock solution in DMSO. All stocks were stored in aliquots at −20 °C. For western blot analysis, 5μM was used for AEB071 and IDE196. For cell cycle analysis, 1 μM and 5 μM for AEB071 and 2 μM and 5 μM for IDE196 were used. For cell viability assay, doses ranging from 0.001 μM to 10 μM for AEB071 and 0.1 μM to 10 μM for IDE196 were used. Transcriptome analysis was performed after treating cells for 24 h with 5 µM IDE196.
+ Open protocol
+ Expand
3

C2C12 Myocyte Culture and Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
C2C12 myocytes were cultured as previously described.64 (link) Briefly, C2C12 myoblasts were grown at 37 °C in a 5% CO2 incubator in Dulbecco’s modified Eagle’s medium (DMEM) (4.5 g/L glucose) (Nacalai Tesque Corp., Kyoto, Japan) supplemented with 10% fetal bovine serum (Equitech-Bio, Inc., Kerrville, TX, USA) and 1% penicillin-streptomycin (Nacalai Tesque Corp.). To induce cell differentiation into myotubes, the medium was changed to DMEM (1.0 g/L glucose) (Nacalai Tesque Corp.) supplemented with 2% horse serum (Thermo Fisher Scientific Inc.) and 1% penicillin-streptomycin (Nacalai Tesque Corp.) for 4 days. Then, experiments using BAs (αMCA and tauro-αMCA; Cayman Chemical, Ann Arbor, MI, USA; Toronto Research Chemical, ON, Canada), palmitic acid (TCI Chemicals, Tokyo, Japan), and sotrastaurin, a PKCθ inhibitor (AEB071; Selleck Chemicals, Houston, TX, USA), were performed following incubation for 4 h in non-supplemented medium.
+ Open protocol
+ Expand
4

T Cell Stimulation and Inhibitor Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
In all experiments, cells were seeded at 2×106 cells/mL and cultured in T cell media consisting of RPMI 1640 supplemented with 10% FBS, 10mM Hepes (pH 7.0), 2mM L-glutamine, 1mM sodium pyruvate, 1x nonessential amino acids, penicillin, streptomycin (all from ThermoFisher, Waltham, MA, USA), and 50μM β-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA). For flow cytometry, 2×106 splenocytes were used per sample. For all other assays 10×106 sorted T cells were used. Cells were stimulated with either 1ug/mL anti-CD3 antibodies (BD Biosciences), 10μg/mL PMA, 1μM thapsigargin (ThermoFisher), or 250ng/mL Ionomycin (Sigma) for the times indicated. In some experiments, cells were pretreated for 30 minutes with the following inhibitors: 10nM Staurosporine, 1μM CID2858522, 100nM 6-Amino-4-(4-phenoxyphenylethylamino)quinazoline (QNZ) (all from MilliporeSigma, Burlington, MA, USA), 10μM AEB071, 5μM SB203580, 0.5μM BIRB796 (all from Selleckchem, Houston, TX, USA), 10μM U0126 (Cell Signaling Technology, Danvers, MA, USA), 10μM BAPTA-AM (ThermoFisher), or DMSO (vehicle) and then activated with either 1ug/mL anti-CD3 antibodies or 10μg/mL PMA for the times indicated. For qRT-PCR experiments, following activation, samples were split in half, with one half (5×106 cells) receiving 1000 U/mL recombinant human IL-2 and the other half receiving no further treatment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!